The Myths and Realities of the Opioid Epidemic AMERSA November 3, 2017

Slides:



Advertisements
Similar presentations
The Intersection of Two Public Health Problems: Under Treatment of Pain and Abuse and Misuse of Pain Medications Richard C. Dart, MD, PhD Director, Rocky.
Advertisements

Delay from Testing HIV Positive until First HIV Care for Drug Users: Adverse Consequences and Possible Solutions Barbara J Turner MD, MSEd* John Fleishman.
The Challenge of Opioid Addiction Valerie Valcour RN, Health District Director Carol Plante, Healthy Lamoille Valley * September 3, 2014.
Monitoring drug related overdose and mortality in Europe Dr. Eva Keller.
TM Centers for Disease Control and Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2011.
Prescription Opioids: Extramedical Use and Overdose
P RESCRIPTION D RUG A BUSE : T HE N ATIONAL P OLICY P ERSPECTIVE Michael Gottlieb, National HIDTA Director Office of National Drug Control Policy May 7,
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
Serving our community by improving health The Addiction Crisis November 2014.
NIDA Grants: U10DA015831, K24DA022288, U10DA020024, K23DA022297, U10DA Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction.
Researched Abuse, Diversion, and Addiction-Related Surveillance Sidney H. Schnoll, M.D., Ph.D.
REDUCING OVERDOSE DEATHS ASSOCIATED WITH PHARMACEUTICAL OPIOID TREATMENT OF CHRONIC PAIN: ANALYZING INTERVENTIONS WITH A SYSTEM DYNAMICS MODEL Wayne Wakeland.
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
Obtaining housing associated with achieving abstinence after detoxification in adults with addiction Tae Woo Park, Christine Maynié-François, Richard Saitz.
State of the State in outcomes: Prescription drug overdoses Karin A. Mack, PhD Senior Behavioral Scientist Prescription Drug Overdose Team National Center.
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
Jennifer R. Havens, PhD, MPH Associate Professor
The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny,
SARAH M. BAGLEY, MD ASSISTANT PROFESSOR OF MEDICINE AND PEDIATRICS BOSTON UNIVERSITY SCHOOL OF MEDICINE AMERSA ANNUAL CONFERENCE NOVEMBER 5, 2015 Overdose.
Pain Management: Narcotics, Implantable Therapies Maher Fattouh MD Adjunct Assistant Clinical Professor University Wisconsin Medical Director, Advanced.
Bystander Naloxone Training Saves Lives. Death rates are spiraling out of control--for both prescription opioids and heroin! Graphic: Nytimes.com.
Poison Center Exposure Calls Predict Mortality due to Prescription Opioid Poisoning Nabarun Dasgupta 1, J. Elise Bailey 2, Richard C. Dart 2,3, Michele.
Medication Adherence and Substance Abuse Predict 18-Month Recidivism among Mental Health Jail Diversion Program Clients Elizabeth N. Burris 1, Evan M.
138 th American Public Health Association Annual Meeting Denver, Colorado November 8, 2010 Determinants of HIV Testing Among High School Students with.
Substance Use Disorders and Overdose: The Basics Public Curricula – Essential Knowledge for Families and Communities Core Component.
The Prescription Opioid & Heroin Crisis: Addiction & Medication Assisted Treatment Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
PRESCRITION DRUG ABUSE and the ELDERLY GREGORY BUNT, M.D. Clinical Assistant Professor of Psychiatry NYU School of Medicine Interim Medical Director Samaritan.
The AMA: Reducing Opioid Abuse in America Patrice A. Harris, MD, MA Board Chair American Medical Association September 2016.
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation.
How big is the problem? The Centers for Disease Control and Prevention (CDC) classifies prescription drug abuse as the fastest growing drug issue and epidemic.
Differences in Treatment Outcome and Current Cognitive and Behavioral Functioning of Individuals Who Received Ibogaine-Assisted Treatment for a SUD Alan.
Daniulaityte, R., Falck, R., & Carlson, R. Introduction
Jessica E. Bates, Pharm.D. PGY-1 Pharmacy Resident
National Health Reform is Essential
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
10th Annual Susan Li Conference
McLean Hospital Division of Alcohol and Drug Abuse
Understanding the Opioid Epidemic
Cognitive Impacts of Ambient Air Pollution in the National Social Health and Aging Project (NSHAP) Cohort Lindsay A. Tallon MSPH1, Vivian C. Pun PhD1,
Opiates: The Big Picture
Challenges and Implications of Postmarketing Surveillance of Prescription Opioids June 29, 2017 Richard C. Dart, MD, PhD Director, Rocky Mountain Poison.
The Epidemiology of Injury and Science of Injury Prevention
Richard C. Dart, MD, PhD Executive Director, RADARS System
ROOM project Addressing the Opioid Epidemic in the U.P.
Know the facts: Series II
Mance E. Buttram, PhD Steven P. Kurtz, PhD
The landscape of prescription drug misuse in the UK
The European Experience: Prescription Drug Misuse in France, Germany, Italy and Spain 24 October 2017 Presented at Lisbon Addictions 2017 Jody L. Green,
Receipt of Medication Treatment after Nonfatal Overdose Among Emerging Adults Sarah M. Bagley, MD, MSc Assistant Professor of Medicine and Pediatrics,
Using Data for Change Barry T. Schmidt, MPH, CPC-R
Other Illicit Drug Use in Delaware: 2018 State Epidemiological Profile
2018 Delaware State Epidemiological Profile
Opioid Use Disorders: Recognition and Pharmacotherapy Review
What do we mean by opioid sparing and what are its potential individual and societal benefits? Eric C. Strain, M.D. Johns Hopkins University School.
Patterns, predictors, and consequences of non-medical use prescription opioids in the Veterans Aging Cohort Study Brandon DL Marshall, PhD Manning Assistant.
The Emerging Threat of Stimulants
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:
ADDICTION
Jim Messina, Ph.D., CCMHC, NCC, DCMHS-T
Substance Use Prevention for Young Adults and Higher Education
Terra L. Armstead MSN, RN, Dr
Alcohol, Other Drugs, and Health: Current Evidence
Strategic Initiatives to Address Opioid Overdose & Addiction
Introduction to Drugs and Society Slide Series 1B
Tapering and Discontinuing Chronic Opioid Therapy
Presentation transcript:

The Myths and Realities of the Opioid Epidemic AMERSA November 3, 2017 Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center Professor, University of Colorado School of Medicine

Competing Interest Statement History 2002, launched by Purdue Pharma L.P. 2006, independent ownership by Denver Health and Hospital Authority Denver Public Hospital for 150 years State sanctioned independent authority Conflict of Interest Statement Many manufacturers of prescription opioids or stimulants as well as federal agencies subscribe to RADARS System. RADARS System is the property of Denver Health and Hospital Authority, a political subdivision of the State of Colorado. Subscribers receive information, but do not participate in developing the System, data collection, or analysis of the data. They do not have access to the raw data. Employees are prohibited from personal financial relationships with any company. 2

What is the Problem We Need to Solve? Filling the Balloon Chewed Crushed Intact Person in Pain Death Outcomes Addiction Overdose Susceptible Person Recreational Abuser Abuse of Other Drugs 3

Opioid Addiction is a Random Event X% of people receiving an opioid analgesic will develop Abuse Abuse behaviors Addiction

Prescription opioid abuse is at record highs and increasing

Prescription Opioid Abuse Decreasing in US Poison Centers Drug Diversion Substance Abuse Treatment Centers Trends in Opioid Analgesic Abuse and Mortality in the United States. N Engl J Med 2015;372:241-8 7

RADARS Poison Center Program Intentional Abuse Exposures Rx Opioid Abuse by API RADARS Poison Center Program Intentional Abuse Exposures Per 100,000 population 8

RADARS Opioid Treatment Program Abuse of IR More Common and ER 9

Deaths in CDC (NVSS) Decreasing (excl heroin & illicit fentanyl) Poison Centers

Prescription Opioids are the Cause of the Opioid Epidemic

Peak Rx Drug Abuse Deaths The problem is Apple! Peak Rx Drug Abuse Deaths 12

Problems with a Reactionary Agenda “OxyContin is the Problem” “Drug manufacturers are the problem” “Addicts / Drug dealers are the problem” The core problem is human frailty and susceptibility to opioids (or perhaps to mind altering substances in general?) When we are looking back at the past… 13

14

Prescription Opioids are One Cause of the Opioid Epidemic

18

Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States OBJECTIVE State medical cannabis laws related to opioid analgesic overdose mortality? DESIGN, SETTING, AND PARTICIPANTS Time-series analysis of medical cannabis laws and state-level death certificate data in the United States from 1999 to 2010; all 50 states were included. Bachhuber MA, et al. JAMA Intern Med. 2014; 174(10): 1668–1673

Deaths from Opioid Analgesic Bachhuber MA, et al. JAMA Intern Med. 2014; 174(10): 1668–1673

National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Methods Associations between cannabis use at wave 1 (2001–2002) and nonmedical prescription opioid use and prescription opioid use disorder at wave 2 (2004–2005) of NESARC. Cannabis and prescription opioid use by structured interview. Other covariates included age, sex, race/ethnicity, anxiety or mood disorders, family history of drug, alcohol, and behavioral problems, and nonmedical opioid use. https://doi.org/10.1176/appi.ajp.2017.17040413

NESARC: Cannabis Use Associated with Increased Opioid Use Cannabis use at wave 1 associated with Increased incident nonmedical prescription opioid use (odds ratio=5.78, 95% CI=4.23–7.90) Increased opioid use disorder (odds ratio=7.76, 95% CI=4.95–12.16) at wave 2 Associations remained significant after adjustment for background characteristics. Among adults with pain at wave 1, cannabis use was also associated Increased incident nonmedical opioid use (adjusted odds ratio=2.99, 95% CI=1.63–5.47) at wave 2

Conclusions Abuse and death of analgesic opioids are decreasing Heroin and illicit fentanyl deaths are increasing more Dramatic changes in heroin distribution has rapidly changing the opioid abuse environment Just call 1-800-Givememyfix Cannabis may or may not affect opioid use Studies to date are intriguing, but more robust analytic designs are needed 23

Questions? Richard.Dart@rmpdc.org